Search research articles
Contact Us
Filters
Showing results (21-30 of 182) with videos related to
Page
of 19
Sort By:
Neuropharmacology
|
February 1, 1982
Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses
D J Heal, C K Atterwill
American Journal of Hematology
|
June 1, 1986
Leukapheresis for control of chronic myelogenous leukemia during pregnancy
D Fitzgerald, J M Rowe, J Heal
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
May 23, 2012
Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes
Alexandra Kennett, David J Heal, Susan Wonnacott
British Journal of Pharmacology
|
September 1, 1990
The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo
P Whitworth, D J Heal, D A Kendall
Psychopharmacology
|
April 1, 1995
Long-lasting effects of an acute stress on the neurochemistry and function of 5-hydroxytryptaminergic neurones in the mouse brain
S Davis, D J Heal, S C Stanford
Journal of Psychopharmacology (Oxford, England)
|
October 16, 2025
Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs
David J Heal, Jane Gosden, Sharon L Smith
Advances in Pharmacology (San Diego, Calif.)
|
March 11, 2024
Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder
David J Heal, Jane Gosden, Sharon L Smith
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
October 24, 2001
Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release
I C Kilpatrick, M Traut, D J Heal
Bailliere'S Clinical Haematology
|
September 1, 1987
Hyperleukocytic leukaemia: rheological and clinical features and management
M A Lichtman, J Heal, J M Rowe
Neuropharmacology
|
February 9, 2012
What is the prognosis for new centrally-acting anti-obesity drugs?
David J Heal, Jane Gosden, Sharon L Smith
Page
of 19
Search research articles
Search
Showing results (21-30 of 182) with videos related to
Sort By:
Page
of 19
Neuropharmacology
|
February 1, 1982
Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses
D J Heal, C K Atterwill
American Journal of Hematology
|
June 1, 1986
Leukapheresis for control of chronic myelogenous leukemia during pregnancy
D Fitzgerald, J M Rowe, J Heal
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
|
May 23, 2012
Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes
Alexandra Kennett, David J Heal, Susan Wonnacott
British Journal of Pharmacology
|
September 1, 1990
The effects of acute and chronic lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo
P Whitworth, D J Heal, D A Kendall
Psychopharmacology
|
April 1, 1995
Long-lasting effects of an acute stress on the neurochemistry and function of 5-hydroxytryptaminergic neurones in the mouse brain
S Davis, D J Heal, S C Stanford
Journal of Psychopharmacology (Oxford, England)
|
October 16, 2025
Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs
David J Heal, Jane Gosden, Sharon L Smith
Advances in Pharmacology (San Diego, Calif.)
|
March 11, 2024
Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder
David J Heal, Jane Gosden, Sharon L Smith
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
October 24, 2001
Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release
I C Kilpatrick, M Traut, D J Heal
Bailliere'S Clinical Haematology
|
September 1, 1987
Hyperleukocytic leukaemia: rheological and clinical features and management
M A Lichtman, J Heal, J M Rowe
Neuropharmacology
|
February 9, 2012
What is the prognosis for new centrally-acting anti-obesity drugs?
David J Heal, Jane Gosden, Sharon L Smith
Page
of 19